Appointment of Nomad

Immupharma PLC
16 November 2007



For Immediate Release                                           16 November 2007

                                                                            

                                  ImmuPharma PLC

                         Appointment of NOMAD and corporate broker

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, 
is pleased to announce the appointment of Panmure Gordon & Co as its NOMAD and 
corporate broker with immediate effect.

For further information, please contact:

ImmuPharma PLC:                                                    020 7152 4080
Richard Warr, Chairman
Dimitri Dimitriou, Chief Executive Officer

Panmure Gordon & Co:                                               020 7459 3600
Andrew Burnett




                      This information is provided by RNS
            The company news service from the London Stock Exchange